PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.47
ESG score 50-60 - Below-average ESG territory. Benjamin Graham would scrutinize governance risks and regulatory exposure. Check Interest Coverage for financial stability.
53.73
Environmental score 50-60 - Below-average environmental territory. Benjamin Graham would scrutinize stranded asset risks and carbon liability exposure.
61.12
Social score 60-70 - Adequate social responsibility that Peter Lynch might accept. Verify if stakeholder management supports long-term brand value and pricing power.
60.56
Governance score 60-70 - Adequate governance that Peter Lynch might accept. Verify if board oversight ensures management acts in shareholder interests.